Sign Up to like & get
recommendations!
1
Published in 2022 at "ACS medicinal chemistry letters"
DOI: 10.1021/acsmedchemlett.2c00408
Abstract: A series of exceptionally selective CDK2 inhibitors are described. Starting from an HTS hit, we successfully scaffold hopped to a 5,7-dihydro-6H-pyrrolo[2,3-d]pyrimidin-6-one core structure, which imparted a promising initial selectivity within the CDK family. Extensive further…
read more here.
Keywords:
pyrrolo pyrimidin;
selective cdk2;
dihydro pyrrolo;
cdk2 inhibitors ... See more keywords